| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Scott William Drake last filed a Form 4 in May 2021, as Director at ATRC. Scott William Drake's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 41,036 shares of ATRC. The ATRC filings lean toward selling, a net 19,922 shares.
Scott William Drake has 9 Form 4 filings on record from May 2015 to May 2021, all as Director at AtriCure (ATRC), 2015–2021.
The 12 reported transactions were 4 stock awards, 2 option exercises, 2 open-market sales and 2 open-market purchases, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 2 purchases worth about $695K and 1 sale worth about $3.4M.
The largest open-market purchase was 12,350 shares of ATRC at an average $40.54 on November 17, 2020, about $501K.
The only open-market sale was 43,272 shares of ATRC at an average $77.75 on May 10, 2021, about $3.4M. Twelve months later ATRC was down 45%.
Shares as reported in the last Form 4 for each company; the most recent is from May 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.